Susan Hasty, Publisher
Table of Contents . . . January 31st, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Blood Weekly | Other Publications
Hemophilia Therapy - Engineered Blood Outgrowth Endothelial Cells Show Promise
Stem Cell Transplantation - Grafts From Different Sources Have Disparate Cell Populations
Acute Myeloid Leukemia - Mismatched Bone Marrow Grafts Feasible As Salvage Therapy
Diabetes Therapy - Erythropoietin With Aminoguanidine Improves Red Blood Cell Deformability
Stem Cell Research - Lentiviral Vectors Effective For Genetic Modification
Thrombosis - Ultrasound Can Help Dissolve Thrombi In Presence of Microbubbles
Alpha-1 Antitrypsin Deficiency - Statewide Screening and Detection Program Launched In Florida
Blood Substitute - Hemopure Overview Presented At Conference
Clotting Factors - Baxter Produces Record Levels of Recombinate rAHF Hemophilia Therapy in 2001
Finance - Medinox Completes $13.8 Million Private Offering
Hemophilia - Viral Vector Revives Clotting Factor In Adult Mice
Hyperlipidemia - Abnormal Coronary Blood Flow Due To Elevated Viscosity
Interstitial Tissue Ablation - Study Results For New GelTx Interstitial Chemo-Gel Treatment Are Encouraging
Sepsis - Vertex Pharmaceuticals Advances New Drug Candidate VX-799
Stem Cell Research - Transporter Molecule Expressed By Stem Cells Acts As Hoechst 33342 Pump
Stem Cell Transplantation - Peripheral Blood Grafts Carry High Levels of Platelet-Related Cytokines
Stem Cell Transplantation - Sirolimus Effective But Dangerous As Salvage Graft-Versus-Host Therapy
Therapy - Millennium Initiates Combination Oncology Trials of MLN341 With Taxotere
Thrombocytopenia - 3-Dimensional Pharmaceuticals Licenses TPO Peptide From GlaxoSmithKline
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.